# Beta-Blockers and Calcium Channel Blockers

> Beta-blockers and calcium channel blockers for NEET-PG Medicine, covering selectivity, indications, adverse effects and interactions in cardiac disease.

- Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/beta-blockers-and-calcium-channel-blockers
- Exam / course: NEET-PG · Subject: Medicine
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-14
- Last updated: 2026-10-14
- Reference basis: KD Tripathi's Essentials of Medical Pharmacology; Goodman and Gilman's The Pharmacological Basis of Therapeutics; Harrison's Principles of Internal Medicine
- How to cite: "Beta-Blockers and Calcium Channel Blockers", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/beta-blockers-and-calcium-channel-blockers

## Direct answer

Beta-blockers and calcium channel blockers are drugs for hypertension, angina and arrhythmias that act on the heart and vessels through different receptors and channels. Beta-1 selective blockers such as metoprolol and bisoprolol are preferred in heart failure with reduced ejection fraction, while dihydropyridines such as amlodipine suit hypertension and angina. Non-dihydropyridines such as verapamil are avoided in heart failure with reduced ejection fraction because they depress contractility.

## What you must remember

- **Selectivity:** propranolol is non-selective, metoprolol, atenolol and bisoprolol are beta-1 selective, and carvedilol and labetalol also block alpha-1 receptors.
- **Beta-blocker indications:** post-myocardial infarction, heart failure with reduced ejection fraction, angina, atrial fibrillation rate control, portal hypertension (propranolol) and migraine prophylaxis.
- **Beta-blocker cautions:** asthma (non-selective agents are avoided), symptomatic bradycardia, heart block and decompensated heart failure.
- **Beta-blocker adverse effects:** fatigue, bradycardia, bronchospasm, masking of hypoglycaemia and rebound tachycardia on abrupt withdrawal.
- **Dihydropyridines:** amlodipine, nifedipine and felodipine are vascular-selective, causing reflex tachycardia, ankle oedema and gingival hyperplasia; amlodipine is neutral in heart failure.
- **Non-dihydropyridines:** verapamil and diltiazem slow atrioventricular conduction, useful in supraventricular tachycardia and rate control, and are avoided in heart failure with reduced ejection fraction.
- **Interactions:** verapamil or diltiazem with a beta-blocker risks heart block, and CYP3A4 inhibitors such as clarithromycin raise amlodipine levels.

## A decision sequence for cardiac patients

A 58-year-old man with stable angina and hypertension asks whether a beta-blocker or a calcium channel blocker suits him better. The choice depends on heart rate, ejection fraction, airway disease and co-medication, and the steps below set out the order.

1. **Check the heart and the airway:** assess ejection fraction, heart rate, atrioventricular conduction, and any asthma or COPD before selecting a class.
2. **Match the indication:** beta-blockers suit post-infarction patients, heart failure with reduced ejection fraction and rate control, while dihydropyridines suit hypertension and angina with normal heart function.
3. **Consider a non-dihydropyridine:** verapamil and diltiazem slow conduction and help supraventricular tachycardia and rate control, but are avoided in heart failure with reduced ejection fraction.
4. **Check interactions:** combining verapamil or diltiazem with a beta-blocker risks heart block, and co-prescribed CYP3A4 inhibitors raise dihydropyridine levels.
5. **Titrate and watch side effects:** monitor heart rate and blood pressure, expect fatigue and ankle oedema, and watch for bronchospasm and masked hypoglycaemia in diabetics.
6. **Taper rather than stop:** withdraw beta-blockers gradually over days to weeks, since sudden stopping can cause rebound tachycardia and ischaemia.

## High-yield viva angles

Viva questions usually test whether the drug suits the heart's pump function and the airway.

- **Trap:** giving verapamil or diltiazem in heart failure with reduced ejection fraction — **Correct:** these are negative inotropes that worsen the pump, so amlodipine or an evidence-based beta-blocker is used instead.
- **Trap:** using a non-selective beta-blocker in asthma — **Correct:** blocking beta-2 receptors causes bronchospasm, so non-selective agents are avoided in asthma.
- **Trap:** choosing propranolol as routine first-line therapy for uncomplicated hypertension — **Correct:** propranolol is non-selective and reserved for specific indications such as portal hypertension and migraine prophylaxis.

## Frequently asked questions

### Why are non-dihydropyridine calcium channel blockers avoided in heart failure?

Verapamil and diltiazem are negative inotropes that depress myocardial contractility, which worsens heart failure with reduced ejection fraction. Amlodipine, a dihydropyridine, is neutral and can be used in heart failure. Evidence-based beta-blockers are preferred for the heart failure itself.

### Which beta-blockers are used with caution in asthma?

Cardioselective beta-1 blockers such as metoprolol, bisoprolol and atenolol are used with caution in asthma, since they have less effect on beta-2 receptors in the airway. Non-selective agents such as propranolol are avoided because they can precipitate bronchospasm. Any asthma patient needs close monitoring when a beta-blocker is started.

### Why do dihydropyridines like nifedipine cause reflex tachycardia?

Nifedipine causes arteriolar vasodilation that lowers blood pressure, and the baroreflex responds with a rise in heart rate. Amlodipine has a slower onset and is less likely to cause this. Ankle oedema is a separate, dose-related effect of dihydropyridines.

### Why are verapamil and diltiazem dangerous when combined with beta-blockers?

Verapamil and diltiazem slow atrioventricular conduction, and beta-blockers add further nodal depression. The combination can cause severe bradycardia or heart block in susceptible patients. Combined use requires careful monitoring or should be avoided.
